$169 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PMVP | Sell | PMV PHARMACEUTICALS INC | $74,726,000 | -35.2% | 3,234,911 | -16.4% | 44.17% | -7.5% |
| REAL | THE REALREAL | $27,331,000 | -11.9% | 2,354,080 | 0.0% | 16.15% | +25.7% | |
| AI | C3.AIcl a | $27,087,000 | -32.6% | 866,774 | 0.0% | 16.01% | -3.8% | |
| SERA PROGNOSTICS | $16,600,000 | -38.2% | 2,416,241 | 0.0% | 9.81% | -11.8% | ||
| GKOS | GLAUKOS CORP | $15,565,000 | -7.7% | 350,264 | 0.0% | 9.20% | +31.7% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $3,970,000 | -22.3% | 764,918 | 0.0% | 2.35% | +10.9% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $2,669,000 | -36.9% | 1,404,515 | 0.0% | 1.58% | -9.9% | |
| VERO | VENUS CONCEPT INC | $1,120,000 | -32.2% | 658,657 | 0.0% | 0.66% | -3.4% | |
| DARE | DARE BIOSCIENCE INC | $124,000 | +19.2% | 62,065 | 0.0% | 0.07% | +69.8% | |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -8,293 | -100.0% | -0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
| EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
| APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
| XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
| CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
| THE REALREAL | 18 | Q3 2023 | 62.6% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
| DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
| MACROGENICS INC | 14 | Q1 2020 | 19.2% |
| PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-27 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-25 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-04-13 |
| 13F-HR | 2022-01-25 |
| 13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.